Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Forster

Showing results (351-360 of 365) with videos related to

Pageof 37
Sort By:
Bulletin of the American Meteorological Society|July 28, 2020
PDRMIP: A Precipitation Driver and Response Model Intercomparison Project, Protocol and preliminary resultsG Myhre, P M Forster, B H Samset, et al.
Nature Communications|January 12, 2018
Impact on short-lived climate forcers increases projected warming due to deforestationC E Scott, S A Monks, D V Spracklen, et al.
PLOS Global Public Health|July 24, 2023
Comparing in-person, blended and virtual training interventions; a real-world evaluation of HIV capacity building programs in 16 countries in sub-Saharan AfricaE Kiguli-Malwadde, M Forster, A Eliaz, et al.
Geophysical Research Letters|January 29, 2019
Understanding Rapid Adjustments to Diverse Forcing AgentsC J Smith, R J Kramer, G Myhre, et al.
Inflammatory Bowel Diseases|July 30, 2025
Preferences, Acceptability, and Utilization of Multimodal Self-Help Interventions in Adults With Inflammatory Bowel Diseases: A Pragmatic Multicenter Study With Patients and CliniciansChung Sang Tse, Melissa G Hunt, James D Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung CancerJeffrey D Bradley, Chen Hu, Ritsuko R Komaki, et al.
Atmospheric Environment (Oxford, England : 1994)|September 8, 2020
The contribution of global aviation to anthropogenic climate forcing for 2000 to 2018D S Lee, D W Fahey, A Skowron, et al.
Nature Immunology|November 25, 2025
Neuroepithelial VIP-VIPR1 interactions differentially control enteric type 1 and type 2 immunityRoksana M Pirzgalska, Beatriz Henriques-Alves, Bruno Raposo, et al.
Journal of Geophysical Research. Atmospheres : JGR|February 7, 2020
Efficacy of Climate Forcings in PDRMIP ModelsT B Richardson, P M Forster, C J Smith, et al.
Neuropharmacology|September 28, 2013
LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disordersLinda M Rorick-Kehn, Jeffrey M Witkin, Michael A Statnick, et al.
Pageof 37

Showing results (351-360 of 365) with videos related to

Sort By:
Pageof 37
Bulletin of the American Meteorological Society|July 28, 2020
PDRMIP: A Precipitation Driver and Response Model Intercomparison Project, Protocol and preliminary resultsG Myhre, P M Forster, B H Samset, et al.
Nature Communications|January 12, 2018
Impact on short-lived climate forcers increases projected warming due to deforestationC E Scott, S A Monks, D V Spracklen, et al.
PLOS Global Public Health|July 24, 2023
Comparing in-person, blended and virtual training interventions; a real-world evaluation of HIV capacity building programs in 16 countries in sub-Saharan AfricaE Kiguli-Malwadde, M Forster, A Eliaz, et al.
Geophysical Research Letters|January 29, 2019
Understanding Rapid Adjustments to Diverse Forcing AgentsC J Smith, R J Kramer, G Myhre, et al.
Inflammatory Bowel Diseases|July 30, 2025
Preferences, Acceptability, and Utilization of Multimodal Self-Help Interventions in Adults With Inflammatory Bowel Diseases: A Pragmatic Multicenter Study With Patients and CliniciansChung Sang Tse, Melissa G Hunt, James D Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung CancerJeffrey D Bradley, Chen Hu, Ritsuko R Komaki, et al.
Atmospheric Environment (Oxford, England : 1994)|September 8, 2020
The contribution of global aviation to anthropogenic climate forcing for 2000 to 2018D S Lee, D W Fahey, A Skowron, et al.
Nature Immunology|November 25, 2025
Neuroepithelial VIP-VIPR1 interactions differentially control enteric type 1 and type 2 immunityRoksana M Pirzgalska, Beatriz Henriques-Alves, Bruno Raposo, et al.
Journal of Geophysical Research. Atmospheres : JGR|February 7, 2020
Efficacy of Climate Forcings in PDRMIP ModelsT B Richardson, P M Forster, C J Smith, et al.
Neuropharmacology|September 28, 2013
LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disordersLinda M Rorick-Kehn, Jeffrey M Witkin, Michael A Statnick, et al.
Pageof 37